'Commercial reasonableness' under Stark: Fair market value's evil twin?

Charles Oppenheim (coppenheim@health-law.com) is a Partner in the Los Angeles office of Hooper, Lundy & Bookman, PC, and is Chair of the firm’s Business department. Amy Joseph (ajoseph@health-law.com) is a Senior Counsel in the Boston office of Hooper, Lundy & Bookman, PC.

Most people in the healthcare industry understand the importance of remuneration being fair market value (FMV), whether in the context of a physician services agreement, practice acquisition, or other transaction with a potential referral source, to meet many exceptions of the federal physician self-referral law, otherwise referred to as the Stark Law.[1]

This document is only available to members. Please log in or become a member.
 


Would you like to read this entire article?

If you already subscribe to this publication, just log in. If not, let us send you an email with a link that will allow you to read the entire article for free. Just complete the following form.

* required field